Online Database of Chemicals from Around the World
Search |  Submit |  中文
Home >> Chemical Listing >> F >> (3R,5S,6E)-7-[4-(4-Fluorophenyl)-2-[[(2-hydroxy-2-methylpropyl)sulfonyl]methylamino]-6-(1-methylethyl)-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic acid calcium salt

(3R,5S,6E)-7-[4-(4-Fluorophenyl)-2-[[(2-hydroxy-2-methylpropyl)sulfonyl]methylamino]-6-(1-methylethyl)-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic acid calcium salt
[CAS# 1714147-47-3]

List of Suppliers
BOC Sciences USA Inquire  
+1 (631) 485-4226
info@bocsci.com
Chemical manufacturer
chemBlink standard supplier since 2010
Leap Chem Co., Ltd. China Inquire  
+86 (852) 3060-6658
market19@leapchem.com
QQ chat
Chemical manufacturer since 2006
chemBlink standard supplier since 2015
Shanghai Forever Synthesis Co.,Ltd. China Inquire  
+86 (551) 6288-8437
+86 18096409024
sales@foreversyn.com
sales02@foreversyn.com
Skype Chat
QQ chat
Chemical distributor since 2013
chemBlink standard supplier since 2018
Complete supplier list of (3R,5S,6E)-7-[4-(4-Fluorophenyl)-2-[[(2-hydroxy-2-methylpropyl)sulfonyl]methylamino]-6-(1-methylethyl)-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic acid calcium salt
Identification
Name (3R,5S,6E)-7-[4-(4-Fluorophenyl)-2-[[(2-hydroxy-2-methylpropyl)sulfonyl]methylamino]-6-(1-methylethyl)-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic acid calcium salt
Molecular Structure CAS # 1714147-47-3, (3R,5S,6E)-7-[4-(4-Fluorophenyl)-2-[[(2-hydroxy-2-methylpropyl)sulfonyl]methylamino]-6-(1-methylethyl)-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic acid calcium salt
Molecular Formula Ca(C25H33FN3O7S)2
Molecular Weight 1117.30
CAS Registry Number 1714147-47-3
Market Analysis Reports
List of Reports Available for (3R,5S,6E)-7-[4-(4-Fluorophenyl)-2-[[(2-hydroxy-2-methylpropyl)sulfonyl]methylamino]-6-(1-methylethyl)-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic acid calcium salt
Related Products
4-(4-Fluorophenyl)-2-hydroxy-6-isopropylpyrimidine-5-carbonitrile  (betaR,deltaR)-2-(4-Fluorophenyl)-delta-hydroxy-beta-methoxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid  4-(4-Fluorophenyl)-3-(4-hydroxy-3-methoxyphenoxymethyl)piperidine  (deltaR)-2-(4-Fluorophenyl)-delta-hydroxy-5-(1-methylethyl)-beta-oxo-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid  (3S,4R)-4-(4-Fluorophenyl)-3-hydroxymethyl-1-methylpiperidine  4-(4-Fluorophenyl)-3-hydroxymethyl-1-methyl-piperidine  (S)-3-(3-Fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one  (R)-3-(3-Fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one  (3S,4R)-4-(4-Fluorophenyl)-3-(hydroxymethyl)-1-piperidinecarboxylic acid phenylmethyl ester  (3S,4R)-4-(4-Fluorophenyl)-3-(hydroxymethyl)-1-piperidinecarboxylic acid tert-butyl ester  (3R,5S,6E)-7-[4-(4-Fluorophenyl)-2-[[(2-hydroxy-2-methylpropyl)sulfonyl]methylamino]-6-(1-methylethyl)-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic acid sodium salt (1:1)  (4S)-3-[(5S)-5-(4-Fluorophenyl)-5-hydroxy-1-oxopentyl]-4-(phenylmethyl)-2-oxazolidinone  (4S)-3-[(5R)-5-(4-Fluorophenyl)-5-hydroxy-1-oxopentyl]-4-phenyl-2-oxazolidinone  (4R)-3-[(5R)-5-(4-Fluorophenyl)-5-hydroxy-1-oxopentyl]-4-phenyl-2-oxazolidinone  (5R)-1-[(5S)-5-(4-Fluorophenyl)-5-hydroxy-1-oxopentyl]-5-phenyl-2-pyrrolidinone  3-[5-(4-Fluorophenyl)-5-hydroxypentanoyl]-4-phenyloxazolidin-2-one  (4S)-3-[(5S)-5-(4-Fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one  3-[(5S)-(4-Fluorophenyl)-5-hydroxypentanoyl]-(4R)-phenyl-1,3-oxazolidin-2-one  (4R,6R)-6-[2-[2-(4-Fluorophenyl)-4-[[(4-hydroxyphenyl)amino]carbonyl]-5-(1-methylethyl)-3-phenyl-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxane-4-acetic acid tert-butyl ester  1-O-[(3R,5R)-7-{2-(4-Fluorophenyl)-4-[(Z)-hydroxy(phenylimino)methyl]-5-isopropyl-3-phenyl-1H-pyrrol-1-yl}-3,5-dihydroxyheptanoyl]-β-D-glucopyranuronic acid